Daniel J. Brat
0000-0002-0633-6563
Publication & Citation Trends
Publications
771 total
Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas
Cited by 1
Semantic Scholar
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment OA
Cited by 168
Semantic Scholar
ROS1 alterations as a potential driver of gliomas in infant, pediatric, and adult patients.
Cited by 7
Semantic Scholar
Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products OA
Cited by 11
Semantic Scholar
Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models OA
Cited by 4
Semantic Scholar
HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen OA
Cited by 3
Semantic Scholar
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma OA
Cited by 3
Semantic Scholar
Myeloid Cell-Derived Creatine in the Hypoxic Niche Promotes Glioblastoma Growth
Cited by 3
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(325)
Cancer, Hypoxia, and Metabolism
(69)
Cancer Genomics and Diagnostics
(61)
Radiomics and Machine Learning in Medical Imaging
(59)
Epigenetics and DNA Methylation
(43)
Affiliations
Northwestern University
University of North Carolina at Chapel Hill
University of Southern California
Roche (Switzerland)
Cedars-Sinai Medical Center